Table 1.
Drugs a | K M (µM) b | Vmax (pmol∙min−1∙pmol CYP−1) c , d | Major CYP | CYP abundance in HLM (pmol/mg) | (µmol) c,d | E T (µM) e | (mL/min) | |
---|---|---|---|---|---|---|---|---|
Canonical f | New g | |||||||
Coumarin | 0.75 | 39.2 | 2A6 | 30.7 ~ 56.2 9 , 22 | 1.77 ~ 5.31 | 1.03 ~ 3.10 | 92,457 ~ 277,683 | 38,924 ~ 54,122 |
Paclitaxel | 5.5 | 4.64 | 2C8 | 26.9 ~ 43.0 9 , 22 | 1.55 ~ 4.06 | 0.90 ~ 2.37 | 1,308 ~ 3,429 | 1,123 ~ 2,396 |
Propafenone | 0.12 | 4.83 | 2D6 | 9.34 ~ 17.2 11 , 22 | 0.54 ~ 1.63 | 0.31 ~ 0.95 | 21,626 ~ 65,339 | 5,982 ~ 7,340 |
Midazolam | 1.6 | 24.4 | 3A4 | 32.6 ~ 60.4 11 , 22 | 1.88 ~ 5.71 | 1.10 ~ 3.33 | 28,630 ~ 87,025 | 16,995 ~ 28,246 |
Indinavir | 2.31 | 9.28 | 7,535 ~ 22,905 | 5,112 ~ 9,382 | ||||
Cyclosporine | 5 | 4.44 | 1,666 ~ 5,063 | 1,366 ~ 3,039 | ||||
Saquinavir | 0.61 | 40.4 | 124,247 ~ 377,671 | 44,443 ~ 58,479 | ||||
Cabazitaxel | 2.1 | 9.5 | 8,499 ~ 25,835 | 5,586 ~ 9,992 | ||||
Docetaxel | 1.1 | 0.20 | 348 ~ 1,059 | 175 ~ 263 | ||||
Valspodar | 1.3 | 2.49 | 3,588 ~ 10,906 | 1,947 ~ 3,062 | ||||
Felodipine | 2.81 | 36.2 | 24,156 ~ 73,427 | 17,381 ~ 33,606 |
, intrinsic clearance of the liver; HLM, human liver microsome; K M, Michaelis‐Menten constant; V max, maximal rate of metabolism.
See Methods for the criteria for the drug selections.
See Supplementary Excel File for references of K M and V max values.
Obtained by dividing the measured rate per mg of the microsomes by the rate per pmol CYP with mean population abundance of CYP (pmol/mg): CYP2A6 (45.37), CYP2C8 (32.30), CYP2D6 (13.26), and CYP3A4 (45.07). 9 , 10 , 11 , 22
The hepatic CYP amount is estimated by multiplying CYP abundance in HLM (pmol/mg) by MPPGL and liver weight (see Methods for details).
The hepatic CYP concentration is estimated based on the assumption that CYPs are evenly distributed (see Methods for details).
Canonical .
New . See Supplementary Excel File for detailed calculation.